Suit, Appeal Over In-Person Dispensing Of Abortion Drug Dropped After FDA Reversal
RICHMOND, Va. — Plaintiffs who challenged the Food and Drug Administration’s requirement that the abortion drug mifepristone be dispensed during in-person health care visits on May 11 voluntarily dismissed their lawsuit,...To view the full article, register now.
Already a subscriber? Click here to view full article